Clinical Research Studies

Are you eligible to participate in this study?

You may be eligible for this study if you meet the following criteria:

• Conditions:
  Mycobacterium Avium Complex
• Age: Between 18 Year(s) - 99 Year(s)
• Gender: Male or Female

• Other Inclusion Criteria:
  

  1. Willing and able to provide written informed consent.

  
  

You may not be eligible for this study if the following are true:

• 1. Patients with any of the following:
     • Predominately fibrocavitary MAC lung disease or cavity >3 cm in diameter;
     • Treatment-refractory MACK lung disease > 5 years;
     • Cystic fibrosis;
     • Active allergic bronchopulmonary mycosis;
     • Anticipated surgery for treatment of MAC lung disease;
     • Disseminated MAC infection;
     • Concomitant pulmonary infection requiring antimicrobial therapy.
  2. Active pulmonary malignancy (primary or metastatic) or any malignancy that required or would require chemotherapy or radiation therapy within 1 year prior to randomization through the last follow up visit.
  3. Creatine clearance < 50 mL/min.
  4. Hemoglobin < 10 g/dl; donation of blood or plasma within 28 days prior to randomization or symptomatic loss of blood within 28 days prior to randomization.
  5. Severe hemoptysis (> 100 mL) within 28 days prior to randomization.
  6. Severe hepatic impairment.
  7. Patients who are pregnant or breastfeeding.
  8. Immunodeficiency.
  9. Patients with an anticipated start of new non-study antimycobacterial therapy to be administered anytime between Screening and Month 6 of this study.